32,209 UnitedHealth Group Incorporated $UNH Shares Sold by Vestor Capital LLC

Vestor Capital LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 98.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 391 shares of the healthcare conglomerate’s stock after selling 32,209 shares during the quarter. Vestor Capital LLC’s holdings in UnitedHealth Group were worth $159,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. General Partner Inc. acquired a new stake in UnitedHealth Group in the third quarter worth $512,000. PBCay One RSC Ltd acquired a new position in shares of UnitedHealth Group during the first quarter valued at $14,343,000. Lee Johnson Capital Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter valued at $6,180,000. Kinsale Capital Group Inc. grew its position in shares of UnitedHealth Group by 13.4% during the second quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock worth $16,006,000 after acquiring an additional 4,557 shares during the last quarter. Finally, Kelleher Financial Advisors increased its holdings in shares of UnitedHealth Group by 135.9% in the 2nd quarter. Kelleher Financial Advisors now owns 5,495 shares of the healthcare conglomerate’s stock worth $2,284,000 after acquiring an additional 3,166 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 1.8%

Shares of NYSE:UNH opened at $404.88 on Wednesday. The company has a 50 day moving average of $390.98 and a 200-day moving average of $364.53. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The firm has a market cap of $362.78 billion, a P/E ratio of 23.12, a P/E/G ratio of 1.44 and a beta of 0.51. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the business earned $2.59 earnings per share. The business’s revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, December 7th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s profits are reportedly improving despite fewer members and lower Optum Health sales, with higher margins and pricing discipline supporting the recovery. Medical-cost pressures remain a risk. Article: Leaner and Meaner: Are UNH’s Profits Getting Bigger?
• Neutral Sentiment: Madeline Bell, former CEO of Children’s Hospital of Philadelphia, joined UnitedHealth’s board. Her healthcare leadership adds experience, though the appointment alone may have limited near-term earnings impact. Article: Madeline Bell Joins UnitedHealth Group Board of Directors
• Neutral Sentiment: A proposed bill would give some ACA marketplace customers a special enrollment period if their provider leaves a plan’s network. It is not enacted, and the potential effect on UNH is uncertain. Article: Right to Re-Enroll Act of 2026
• Negative Sentiment: UnitedHealth plans to drop Medicare coverage in 140 counties and leave Wyoming. The pullback could reduce membership and revenue in affected markets, although exiting areas with unfavorable economics may help control costs. Article: UnitedHealth Group Will Drop Medicare Plans In 140 Counties And Leave Wyoming

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on UNH. Stephens set a $500.00 price objective on shares of UnitedHealth Group in a research report on Friday, October 16th. New Street Research set a $402.00 target price on shares of UnitedHealth Group in a research report on Friday, October 9th. HC Wainwright set a $500.00 price target on shares of UnitedHealth Group in a research note on Friday, October 16th. Royal Bank Of Canada lifted their price target on UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a report on Tuesday, October 20th. Finally, Morgan Stanley boosted their price objective on UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 27th. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $463.93.

UnitedHealth Group Company Profile

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.